description: Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
problem types: CWE-284 Improper Access Control
affected:
{
product: Omnipod Insulin Management System
vendor: Insulet
versions:
status: affected, version: 19191
status: affected, version: 40160
status: affected, version: ZXP425
status: affected, version: ZXR425
}
metrics:
cvssV3_1: [
attackComplexity: LOW
attackVector: LOCAL
availabilityImpact: LOW
baseScore: 7.3
baseSeverity: HIGH
confidentialityImpact: LOW
integrityImpact: HIGH
privilegesRequired: NONE
scope: UNCHANGED
userInteraction: NONE
vectorString: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
version: 3.1
]
workarounds: Insulet recommends patients using the affected products talk to their healthcare provider about the risks of continued use, including the possibility of changing to the latest model with increased cybersecurity protection.
Additionally, Insulet recommends all patients take the cybersecurity precautions indicated below.
Do not connect to or allow any third-party devices to be connected to or use any software not authorized by Insulet.
Maintain tight physical control of the pump and devices connected to the pump.
Be attentive to pump notifications, alarms, and alerts.
Immediately cancel any unintended boluses (a single dose of insulin administered all at once).
Monitor blood glucose levels closely and act as appropriate.
Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis or if you suspect insulin pump settings or insulin delivery has changed unexpectedly.
Insulet has released additional patient-focused information: https://www.myomnipod.com/security-bulletins
More information is available regarding Insulet’s product security and vulnerability management: https://www.myomnipod.com/product-security